tiprankstipranks
Advertisement
Advertisement
Aeon receives additional notice related to NYSE American listing standards
PremiumThe FlyAeon receives additional notice related to NYSE American listing standards
4M ago
AEON Biopharma Receives Additional NYSE American Noncompliance Notice
Premium
Company Announcements
AEON Biopharma Receives Additional NYSE American Noncompliance Notice
4M ago
Is AEON a Buy, Before Earnings?
Premium
Pre-Earnings
Is AEON a Buy, Before Earnings?
4M ago
AEON Biopharma Advances Biosimilar Program and Debt Reduction
PremiumCompany AnnouncementsAEON Biopharma Advances Biosimilar Program and Debt Reduction
6M ago
Aeon Biopharma reports BPD Type 2a meeting with FDA
Premium
The Fly
Aeon Biopharma reports BPD Type 2a meeting with FDA
6M ago
AEON Biopharma Releases Updated Investor Presentation Under Reg FD
Premium
Company Announcements
AEON Biopharma Releases Updated Investor Presentation Under Reg FD
7M ago
Aeon Biopharma reports Q3 EPS (39c) vs ($11.24) last year
PremiumThe FlyAeon Biopharma reports Q3 EPS (39c) vs ($11.24) last year
9M ago
AEON Biopharma Announces New Securities Purchase Agreement
Premium
Company Announcements
AEON Biopharma Announces New Securities Purchase Agreement
9M ago
Aeon Biopharma announces FDA BPD Type 2a meeting for ABP-450
Premium
The Fly
Aeon Biopharma announces FDA BPD Type 2a meeting for ABP-450
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100